Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gumy-Pause

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Leukemia|November 25, 2003
ATM gene and lymphoid malignanciesF Gumy-Pause, P Wacker, A-P Sappino
Pediatric Hematology and Oncology|February 7, 2014
Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old childNathalie Rock, V Mattiello, C Judas, et al.
Free Radical Biology & Medicine|March 24, 2015
The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell linesS Carnesecchi, A-L Rougemont, J H Doroshow, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|February 28, 2025
Intracardiac myoepithelial carcinoma with EWSR1::KLF15 fusion: A rare case of pediatric primary cardiac malignancyL Mwizerwa, V L Cousin, T Sologashvili, et al.
Oncogenesis|April 5, 2013
The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damageA-P Sappino, R Buser, Q Seguin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2011
Do NK cells contribute to the pathophysiology of transplant-associated thrombotic microangiopathy?M Ansari, M Vukicevic, A L Rougemont, et al.
The Pharmacogenomics Journal|October 29, 2021
Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantationC R S Uppugunduri, P Huezo-Diaz Curtis, T Nava, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Leukemia|November 25, 2003
ATM gene and lymphoid malignanciesF Gumy-Pause, P Wacker, A-P Sappino
Pediatric Hematology and Oncology|February 7, 2014
Treatment of an acute promyelocytic leukemia relapse using arsenic trioxide and all-trans-retinoic in a 6-year-old childNathalie Rock, V Mattiello, C Judas, et al.
Free Radical Biology & Medicine|March 24, 2015
The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell linesS Carnesecchi, A-L Rougemont, J H Doroshow, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|February 28, 2025
Intracardiac myoepithelial carcinoma with EWSR1::KLF15 fusion: A rare case of pediatric primary cardiac malignancyL Mwizerwa, V L Cousin, T Sologashvili, et al.
Oncogenesis|April 5, 2013
The CEACAM1 tumor suppressor is an ATM and p53-regulated gene required for the induction of cellular senescence by DNA damageA-P Sappino, R Buser, Q Seguin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2011
Do NK cells contribute to the pathophysiology of transplant-associated thrombotic microangiopathy?M Ansari, M Vukicevic, A L Rougemont, et al.
The Pharmacogenomics Journal|October 29, 2021
Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantationC R S Uppugunduri, P Huezo-Diaz Curtis, T Nava, et al.
Pageof 1